Evidence map›Paper›PMID 35404783›Full record

ArticleMicrobial genomics2022

Piperacillin/tazobactam-resistant, cephalosporin-susceptible

Thomas Edwards, Eva Heinz, Jon van Aartsen, Alex Howard, Paul Roberts, Caroline Corless, Alice J Fraser, Christopher T Williams, Issra Bulgasim, Luis E Cuevas and 5 more

Abstract read
In one paragraph

Article in Microbial genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Shifts inMicrobiology spectrum · 2025
    Article
  4. Article
  5. Article
  6. Molecular Analysis ofMicroorganisms · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Thomas EdwardsDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Eva HeinzDepartment of Vector Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Jon van AartsenLiverpool University Hospital Foundation Trust, Prescot street, Liverpool, L7 8XP, UK.
Alex HowardLiverpool University Hospital Foundation Trust, Prescot street, Liverpool, L7 8XP, UK.
Paul RobertsLiverpool University Hospital Foundation Trust, Prescot street, Liverpool, L7 8XP, UK.
Caroline CorlessLiverpool University Hospital Foundation Trust, Prescot street, Liverpool, L7 8XP, UK.
Alice J FraserDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Christopher T WilliamsDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Issra BulgasimDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Luis E CuevasDepartment of Vector Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Christopher M ParryDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Adam P RobertsDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Emily R AdamsDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Jenifer MasonLiverpool University Hospital Foundation Trust, Prescot street, Liverpool, L7 8XP, UK.
Alasdair T M HubbardDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.

Funding

Medical Research Council MR/S004793/1Wellcome TrustWellcome Trust 217303/Z/19/Z
6 · The paper itself

Abstract

Resistance to piperacillin/tazobactam (TZP) in

Indexed as

Escherichia coli InfectionsSepsisAnti-Bacterial AgentsCephalosporinsEscherichia coliHumansPiperacillin, Tazobactam Drug CombinationAnti-Bacterial AgentsCephalosporinsPiperacillin, Tazobactam Drug CombinationAMRbloodstream infectionEscherichia colipiperacillin/tazobactamresistance

Identifiers

PMID35404783
PMCPMC9453079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.